Improvement in latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint in rheumatoid arthritis.
about
Challenges in longitudinal exposure-response modeling of data from complex study designs: a case study of modeling CDAI score for ustekinumab in patients with Crohn's disease.Exposure-Response Modeling and Power Analysis of Components of ACR Response Criteria in Rheumatoid Arthritis (Part 2: Continuous Model).Exposure-Response Modeling and Power Analysis of Components of ACR Response Criteria in Rheumatoid Arthritis (Part 1: Binary Model).Improvement in latent variable indirect response modeling of multiple categorical clinical endpoints: application to modeling of guselkumab treatment effects in psoriatic patients.Landmark and longitudinal exposure-response analyses in drug development.
P2860
Improvement in latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint in rheumatoid arthritis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Improvement in latent variable ...... point in rheumatoid arthritis.
@en
type
label
Improvement in latent variable ...... point in rheumatoid arthritis.
@en
prefLabel
Improvement in latent variable ...... point in rheumatoid arthritis.
@en
P2860
P1476
Improvement in latent variable ...... point in rheumatoid arthritis.
@en
P2093
Chuanpu Hu
Honghui Zhou
P2860
P2888
P356
10.1007/S10928-015-9453-X
P577
2015-11-09T00:00:00Z